Skip to content

EXOZ EXOZ EBITDA

EBITDA at other companies

Gevo logo
GevoGEVO
$1.96M+114%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$58.58M+11.5%
NAG
Niagen Bioscience, Inc. Common StockNAGE
$1.87M-62.4%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$12.77M+32.0%
Opko Health logo
Opko HealthOPK
-$28.82M+34.0%
Upexi logo
UpexiUPXI
-$106.68M-3,066%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Calculated from EXOZ’s reported figures.

$2.4Mebit+
$74.1KDepreciation Depletion & Amortization
=-$2.31M

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's EBITDA?
EXOZ (EXOZ) reported EBITDA of -$2.31M in Q1 2026.
How has EXOZ's EBITDA changed year-over-year?
EXOZ's EBITDA decreased by 23.0% year-over-year, from -$1.88M to -$2.31M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.